|
The distribution of stained cells in GAP patients and the controls. |
||||
| GAP Group |
Control Group |
|||
|
|
||||
| N |
% |
N |
% |
|
|
|
||||
| Cas-3 grade 0 |
4 |
50 |
6 |
60 |
| Cas-3 grade 1 |
4 |
50 |
4 |
40 |
|
|
||||
| p53 grade 1 |
- |
- |
4 |
40 |
| p53 grade 2 |
5 |
62.5 |
2 |
20 |
| p53 grade 3 |
3 |
37.5 |
4 |
40 |
|
|
||||
| Bcl-2 grade 1 |
- |
- |
6 |
60 |
| Bcl-2 grade 2 |
2 |
25 |
4 |
40 |
| Bcl-2 grade 3 |
6 |
75 * |
- |
- |
|
* Significant difference (P < 0.05) | ||||
Bulut et al. Head & Face Medicine 2006 2:17 doi:10.1186/1746-160X-2-17 |
||||